ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Gut Microbial Genetic Variation Prolongs Host Healthy Longevity and Remodels Metabolome and Proteome in Drosophila Melanogaster.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Review
- Article
- Gut Microbial Genetic Variation Prolongs Host Healthy Longevity and Remodels Metabolome and Proteome in Drosophila Melanogaster.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Microbial genetic variation plays a crucial role in shaping host-microbe interactions; however, its impact on healthy aging remains largely unexplored. This study investigates how genetic variations in gut-residing Saccharomyces cerevisiae affect the health and lifespan of Drosophila melanogaster. This study identifies 14 yeast mutants that significantly extended the lifespan of D. melanogaster, with 13 mutants enhancing locomotor function in aged flies and two mutants improving reproductive capacity. Metabolomic and proteomic analyses reveal that these mutant yeasts rejuvenate the metabolic state of the aging gut and alter protein levels in tissues outside the gut. Most of the proteins with at least a two-fold change are upregulated. The data also highlights mitochondrial energy metabolism as a key anti-aging mechanism driven by the yeast. Notably, terpenoid metabolites such as ergosterol acetate showed strong lifespan-extending effects and may influence energy metabolism. In conclusion, these findings establish a strong link between gut metabolic status and healthy aging, underscoring the significance of the microbial-host mitochondrial axis as a key mechanism by which gut microbes promote host health and longevity. Furthermore, genetically engineered probiotics in model organisms offer a promising potential strategy for extending healthy lifespan, thus meriting further investigation in translational research models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.